Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 157923, 11 pages
http://dx.doi.org/10.1155/2014/157923
Research Article

Evaluation of Inhibitory Effect of Recreational Drugs on Dopaminergic Terminal Neuron by PET and Whole-Body Autoradiography

1Department of Biomedical Imaging and Radiological Sciences, National Yang Ming University, Taipei 11221, Taiwan
2Department of Education and Research, Taipei City Hospital, Taipei 10341, Taiwan
3Biophotonic and Molecular Imaging Research Center, National Yang Ming University, Taipei 11221, Taiwan
4Division of Nuclear Medicine, Taipei City Hospital Zhongxiao Branch, Taipei 11556, Taiwan
5Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, TX, USA
6Molecular and Genetic Imaging Core/Taiwan Mouse Clinic, National Comprehensive Mouse Phenotyping and Drug Testing Center, Taipei 11533, Taiwan
7National PET/Cyclotron Center and Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei 11221, Taiwan
8Nuclear Medicine Department and PET-CT Center, Shuang Ho Hospital Ministry of Health and Welfare, Taipei Medical University, New Taipei City 23561, Taiwan
9Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan

Received 27 February 2014; Accepted 27 March 2014; Published 29 April 2014

Academic Editor: David J. Yang

Copyright © 2014 Skye Hsin-Hsien Yeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Tuomela, S. Forsback, L. Haavisto et al., “Enzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma,” EJNMMI Research, vol. 3, no. 1, p. 18, 2013. View at Publisher · View at Google Scholar
  2. A. Imperiale, P. Addeo, G. Averous, I. J. Namer, and P. Bachellier, “Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on 18F-FDOPA PET/CT,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 7, pp. 2643–2644, 2013. View at Publisher · View at Google Scholar
  3. S. P. Hume, A. A. Lammertsma, R. Myers et al., “The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease,” Journal of Neuroscience Methods, vol. 67, no. 2, pp. 103–112, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Ishiwata, N. Ogi, N. Hayakawa et al., “Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone,” Nuclear Medicine and Biology, vol. 29, no. 3, pp. 307–316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Tsukada, J. Kreuter, C. E. Maggos et al., “Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography,” Journal of Neuroscience, vol. 16, no. 23, pp. 7670–7677, 1996. View at Google Scholar · View at Scopus
  6. P. K. Thanos, N. B. Taintor, D. Alexoff et al., “In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET,” Journal of Nuclear Medicine, vol. 43, no. 11, pp. 1570–1577, 2002. View at Google Scholar
  7. L. Martiniova, S. Cleary, E. W. Lai et al., “Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma,” Nuclear Medicine and Biology, vol. 39, no. 2, pp. 215–226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. O. H. G. Wilder-Smith, L. Arendt-Nielsen, D. Gäumann, E. Tassonyi, and K. R. Rifat, “Sensory changes and pain after abdominal hysterectomy: a comparison of anesthetic supplementation with fentanyl versus magnesium or ketamine,” Anesthesia and Analgesia, vol. 86, no. 1, pp. 95–101, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Shewan and P. Dalgarno, “Ecstasy and neurodegeneration. ...such as ketamine,” BMJ, vol. 313, no. 7054, p. 424, 1996. View at Google Scholar · View at Scopus
  10. S. M. Yentis, N. Hirsch, and G. Smith, Eds., Anaesthesia and Intensive Care A-Z, Butterworth-Heinemann, 2003.
  11. NIDA, Methamphetamine: Abuse and Addiction, 2006.
  12. A. M. Barr, W. J. Panenka, G. W. MacEwan et al., “The need for speed: an update on methamphetamine addiction,” Journal of Psychiatry and Neuroscience, vol. 31, no. 5, pp. 301–313, 2006. View at Google Scholar · View at Scopus
  13. R. M. Murray, A. Paparelli, P. D. Morrison, A. Marconi, and M. Di Forti, “What can we learn about schizophrenia from studying the human model, drug-induced psychosis?” American Journal of Medical Genetics. Part B, vol. 162B, no. 7, pp. 661–670, 2013. View at Publisher · View at Google Scholar
  14. Y. Mateo, E. A. Budygin, C. E. John, and S. R. Jones, “Role of serotonin in cocaine effects in mice with reduced dopamine transporter function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 372–377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Ishiwata, M. Shinoda, S.-I. Ishii, T. Nozaki, and M. Senda, “Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism,” Nuclear Medicine and Biology, vol. 23, no. 3, pp. 295–301, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Jokinen, M. Karrasch, A. Brück, J. Johansson, J. Bergman, and J. O. Rinne, “Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction,” Journal of the Neurological Sciences, vol. 329, no. 1-2, pp. 23–28, 2013. View at Publisher · View at Google Scholar
  17. K. Kyono, T. Takashima, Y. Katayama et al., “Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats,” EJNMMI Research, vol. 1, no. 1, p. 25, 2011. View at Google Scholar
  18. C. K. Fang, H. W. Chen, W. H. Wang, R. S. Liu, and J. J. Hwang, “Acute effects of three club drugs on the striatum of rats: evaluation by quantitative autoradiography with [18F]FDOPA,” Applied Radiation and Isotopes, vol. 77, pp. 153–159, 2013. View at Publisher · View at Google Scholar
  19. H. Yamanaka, C. Yokoyama, H. Mizuma et al., “A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques,” Translational Psychiatry, vol. 4, p. e342, 2014. View at Publisher · View at Google Scholar
  20. C. Wang, D. Zheng, J. Xu, W. Lam, and D. T. Yew, “Brain damages in ketamine addicts as revealed by magnetic resonance imaging,” Frontiers in Neuroanatomy, vol. 7, p. 23, 2013. View at Publisher · View at Google Scholar
  21. C. W. Chang, H. E. Wang, H. M. Lin, C. S. Chtsai, J. B. Chen, and R.-S. Liu, “Robotic synthesis of 6-[18F]fluoro-L-dopa,” Nuclear Medicine Communications, vol. 21, no. 9, pp. 799–802, 2000. View at Google Scholar · View at Scopus
  22. K.-J. Lin, X.-X. Ye, T.-C. Yen et al., “Biodistribution study of [123I] ADAM in mice: correlation with whole body autoradiography,” Nuclear Medicine and Biology, vol. 29, no. 6, pp. 643–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. C. W. George Paxinos, Ed., The Rat Brain in Stereotaxic Coordinates, Academic Press, 4th edition, 1998.
  24. S. Nikolaus, R. Larisch, M. Beu, H. Vosberg, and H.-W. Müller-Gärtner, “Imaging of striatal dopamine D2 receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with 18F-(N-methyl)benperidol,” Journal of Nuclear Medicine, vol. 42, no. 11, pp. 1691–1696, 2001. View at Google Scholar · View at Scopus
  25. H. H. Yeh, K. Ogawa, J. Balatoni et al., “Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 4, pp. 1603–1608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Tsukada, N. Harada, S. Nishiyama, H. Ohba, and T. Kakiuchi, “Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis,” Brain Research, vol. 860, no. 1-2, pp. 141–148, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. L. K. M. Wright, E. C. Pearson, T. G. Hammond, and M. G. Paule, “Behavioral effects associated with chronic ketamine or remacemide exposure in rats,” Neurotoxicology and Teratology, vol. 29, no. 3, pp. 348–359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Usun, S. Eybrard, F. Meyer, and A. Louilot, “Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex,” Behavioural Brain Research, vol. 256, pp. 229–237, 2013. View at Publisher · View at Google Scholar
  29. F. X. Vollenweider, P. Vontobel, I. Øye, D. Hell, and K. L. Leenders, “Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans,” Journal of Psychiatric Research, vol. 34, no. 1, pp. 35–43, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. N. M. Selby, J. Anderson, P. Bungay, L. J. Chesterton, and N. V. Kolhe, “Obstructive nephropathy and kidney injury associated with ketamine abuse,” NDT Plus, vol. 1, no. 5, pp. 310–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Y. Yeung, J. A. Rudd, W. P. Lam, Y. T. Mak, and D. T. Yew, “Mice are prone to kidney pathology after prolonged ketamine addiction,” Toxicology Letters, vol. 191, no. 2-3, pp. 275–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. E. Autry, M. Adachi, E. Nosyreva et al., “NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses,” Nature, vol. 475, no. 7354, pp. 91–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. D. Walker, K. Dinelle, R. Kornelsen et al., “In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET,” Journal of Cerebral Blood Flow & Metabolism, vol. 33, no. 1, pp. 59–66, 2013. View at Publisher · View at Google Scholar
  34. M. J. Hunt, K. Kessal, and R. Garcia, “Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats,” Journal of Neuroscience, vol. 25, no. 2, pp. 524–531, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Z. Reus, H. M. Abelaira, M. A. dos Santos et al., “Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors,” Behavioural Brain Research, vol. 256, pp. 451–456, 2013. View at Publisher · View at Google Scholar